ReVive Biotechnology

ReVive Biotechnology is dedicated to enhancing lives through groundbreaking clinical therapeutics. Operating from its base in Research Park at the University of Illinois, Urbana-Champaign, ReVive Biotechnology benefits from access to cutting-edge laboratories and facilities that foster innovation and progress.

With a clear focus on improving oxygen delivery to hypoxic tissues, ReVive Biotechnology utilizes advanced nanotechnology to develop innovative solutions. The company’s research and development efforts are currently centered on creating a treatment for central retinal artery occlusion (CRAO), with future applications anticipated for other ocular ischemic conditions, as well as hypoxic conditions in various organ systems. ReVive Biotechnology is committed to navigating the regulatory landscape to secure FDA approval for this potentially revolutionary therapeutic, building on successful pre-clinical studies that have already demonstrated proof of concept.

ReVive Biotechnology, located in Champaign-Urbana, Illinois, US, is poised to make significant contributions to the field of biotechnology. We encourage the management team to create a customized and exclusive company showcase and product listing on our platform to highlight their achievements further.